Applications are now open for designated RN prescribers to get a PBS prescriber number. The Chief Nurse has shared the latest milestones and a new one-stop website for nurses and employers.
Thinking about leading your own clinical trial? A new directory brings together the key Australian and NSW resources for investigator-initiated cancer trials, mapped to each stage from concept to activation.
Gain practical insights into understanding and responding to the evolving needs of people living with CML, from diagnosis through treatment and beyond.
In this webinar recording, Dr Raquel Ruiz Araujo shares practical insights into recognising and managing these reactions, including those caused by EGFR inhibitors.
As of 1 September 2026, nurse practitioners have been able to prescribe PBS-listed medicines for chronic myeloid leukaemia (CML) as a continuation of an existing therapy, where care is shared with a medical practitioner.
